Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024
Clinicopathologic Conference, Anti-IgLON5 IgG-Associated Neurologic Disorder
NEJM 386:173-180, Case 1-2022, 2022
Disabling Jaw Clonus in a Patient with Bulbar-Onset Amyotrophic Lateral Sclerosis Successfully Treated with Botulinum Toxin
Neurol 99:671, Santos, M.O.,et al, 2022
A Child with Arthrogryposis
Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018
A 64-year-old Man with Progressive Paraspinal Muscle Weakness
Neurol 86:e4-e9, Schneider, R.,et al, 2016
Degenerative Diseases of the Nervous System, Amyotrophic Lateral Sclerosis
Adams & Victors Principles of Neurology, Chp 39, pg 1109, Ropper, A.H.,et al, 2014
Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008
Human Botulism Immune Globulin for the Treatment of Infant Botulism
NEJM 354:462-471, Arnon,S.S.,et al, 2006
Polymyositis Masquerading as Motor Neuron Disease
Arch Neurol 60:1001-1003, Ryan,A.,et al, 2003
Botulinum Toxin as a Biological Weapon
JAMA 285:1059-1070, Arnon,S.S.,et al, 2001
Adult Botulism
Muscle & Nerve, 20:100-10297., Shapiro,B.E.,et al, 1997
Botulism in an Adult Associated with Food-Borne Intestinal Infection with Clostridium Botulinum
NEJM 315:239-241, 254-2551986., Chia,J.K.,et al, 1986